Cyndeo Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.82M | Buy |
44,870
+1,586
| +4% | +$170K | 0.29% | 96 |
|
|
2025
Q1 | $4.37M | Buy |
43,284
+4,383
| +11% | +$442K | 0.29% | 100 |
|
|
2024
Q4 | $3.47M | Buy |
38,901
+3,191
| +9% | +$285K | 0.23% | 110 |
|
|
2024
Q3 | $2.99M | Sell |
35,710
-9,856
| -22% | -$826K | 0.21% | 128 |
|
|
2024
Q2 | $3.51M | Buy |
45,566
+912
| +2% | +$70.2K | 0.27% | 107 |
|
|
2024
Q1 | $3.06M | Sell |
44,654
-6,286
| -12% | -$431K | 0.25% | 113 |
|
|
2023
Q4 | $2.94M | Sell |
50,940
-26,397
| -34% | -$1.53M | 0.27% | 107 |
|
|
2023
Q3 | $4.08M | Buy |
77,337
+6,321
| +9% | +$334K | 0.43% | 76 |
|
|
2023
Q2 | $3.84M | Sell |
71,016
-16,202
| -19% | -$876K | 0.4% | 82 |
|
|
2023
Q1 | $4.36M | Buy |
87,218
+13,253
| +18% | +$663K | 0.47% | 63 |
|
|
2022
Q4 | $3.42M | Buy |
+73,965
| New | +$3.42M | 0.4% | 85 |
|